CD79A and COVID-19: The IBMP ELISA IgA/IgM/IgG COVID-19, GOLD ELISA COVID-19 IgG/IgM, and Anti-SARS-CoV-2 IgG ELISA detect seroconversion in the first week post symptom onset.